NIH-funded research R01 grant

Targeting a Ferroptosis Defense Pathway in Pancreatic Cancer

Official title: Targeting a Novel Ferroptosis Defense Pathway in Pancreatic Cancer

Funded at Ut Southwestern Medical Center · NIH-11449121 · Data updated 2026-11-12

Aimed at pancreatic cancer, this grant tests a new way to trigger cancer cell death by ferroptosis (a iron-driven form of cell death) and overcomes resistance tied to KRAS signaling.

More Pancreatic Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUt Southwestern Medical Center
NIH-funded
Lab location1 site (Dallas, United States)
Project startAugust 1, 2026
Project endJuly 31, 2031
Funding year2026
Award (this year)$404,922
NIH project number1R01CA307561-01A1
Project IDNIH-11449121 on NIH RePORTER

Who could benefit from this research

Could help

Patients with pancreatic ductal adenocarcinoma (PDAC) who may benefit from future ferroptosis-based therapies.

Less likely to help

This preclinical grant may not directly benefit patients in the near term but could inform future therapies for those with PDAC.

What this research studies

Pancreatic cancer is notoriously hard to treat because cancer cells dodge traditional death pathways. This project focuses on a ferroptosis-based strategy, exploring how cancer cells suppress this death route and how to overcome that suppression. Scientists identified CYCS as a key player that helps cancer cells avoid ferroptosis and are studying how inhibiting this pathway could make tumors more vulnerable. The work uses genetic screens and cellular models to understand the mechanics and tests a small molecule, 10A3, that may promote ferroptosis in pancreatic cancer cells. The goal is to lay the groundwork for new therapies that specifically push pancreatic tumors toward ferroptotic death.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that make pancreatic tumors more responsive to therapy by unleashing ferroptosis.

How similar studies have gone: Previous studies have shown that manipulating ferroptosis pathways can influence cancer cell death, with growing evidence supporting this approach in resistant tumors.

Where this research is happening

  • Ut Southwestern Medical Center
    Dallas, United States
    Active

Researchers

  • Principal investigator: Song, Xinxin — Ut Southwestern Medical Center
  • Study coordinator: Song, Xinxin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.